Form 4: Select Medical Holdings Corp: VP of Compliance Acquires 7,000 Shares of Restricted Stock

Sentiment:

SEC Form 4 Filing


Robert G. Breighner JR, Vice President of Compliance at Select Medical Holdings Corp, acquired 7,000 shares of restricted stock on April 29, 2025, which will vest on April 29, 2029.

Summary

  • Robert G. Breighner JR, the Vice President of Compliance at Select Medical Holdings Corporation, filed a Form 4 indicating changes in beneficial ownership.
  • On April 29, 2025, Breighner acquired 7,000 shares of Select Medical Holdings Corp (SEM) common stock.
  • These shares were granted as restricted stock at a price of $0 per share.
  • The restricted stock will vest on April 29, 2029, which is the fourth anniversary of the grant date.
  • Following the transaction, Breighner directly owns 37,356 shares of Select Medical Holdings Corp.
  • The filing was signed by Michael E. Tarvin, Attorney-in-Fact, on April 30, 2025.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. It reflects a standard executive compensation practice, indicating confidence in the company's future, but doesn't contain any groundbreaking news.

Positives

  • The acquisition of restricted stock aligns the executive's interests with the long-term performance of the company.
  • The vesting schedule encourages continued service and commitment from the VP of Compliance.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting schedule of the restricted stock suggests an expectation of continued employment and contribution from the executive.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency regarding the transactions of company insiders. This filing indicates a standard compensation practice of granting restricted stock to executives.

Stakeholder Impact

  • The grant of restricted stock aligns management's interests with those of shareholders, potentially encouraging decisions that benefit long-term shareholder value.

Key Dates

DateDescription
04/29/2025Date of transaction: Grant of 7,000 shares of restricted stock.
04/29/2029Vesting date of the restricted stock (fourth anniversary of the grant date).
04/30/2025Date of Form 4 signature by Attorney-in-Fact.

Keywords

Form 4, Beneficial Ownership, Restricted Stock, Select Medical Holdings, SEM, Breighner, Compliance, Vesting

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.